MENU

GBMC: COVID-19 & The Impact on Cancer Care

Due to the COVID-19 pandemic, more people with cancer are going undiagnosed and untreated. The COVID-19 pandemic has reduced cancer treatment, screening and diagnostic testing as well as clinical trials and research. Additionally, there have been less visits and referrals, which have in turn, led to disruptions in cancer care. Brandon Costantino, Oncology Support Program Manager from the Sandra & Malcolm Berman Cancer Institute at GBMC explains why it's important for patients to maintain their care.

FOLLOW US ON TWITTER